SavedAdd your journal

Journals / Medicine Science / 2020 / Cilt: 9 - Sayı: 1

Plasmapheresis as treatment for patients with severe hypertriglyceridemia

Okan Sefa BAKİNER
Pages
274–277
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article effect and mechanisms of plasmapheresis on SHTG and related acute pancreatitis will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Severe hypertriglyceridemia (SHGT) occurs when triglyceride values exceed 1,000 mg/dl which places patients at considerable risk of acute pancreatitis.
📊
Key Findings & Data:Insulin infusion is considered to decrease triglyceride levels in patients who display SHTG related acute pancreatitis.
💡
Conclusion & Impact:In this article effect and mechanisms of plasmapheresis on SHTG and related acute pancreatitis will be discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Severe hypertriglyceridemia (SHGT) occurs when triglyceride values exceed 1,000 mg/dl which places patients at considerable risk of acute pancreatitis. Treatment of SHGT includes lipid lowering approches and dietary interventions. Insulin infusion is considered to decrease triglyceride levels in patients who display SHTG related acute pancreatitis. Plasmapheresis is an effective method and an extracorporeal process which may be used both in urgent and in selective cases. Plasma exchange and double cascade filtration are methods of plasmapheresis used in SHTG and possible following acute pancreatitis. In this article effect and mechanisms of plasmapheresis on SHTG and related acute pancreatitis will be discussed.

🔖

Cite This Article

BAKİNER, O. S. (2020). Plasmapheresis as treatment for patients with severe hypertriglyceridemia. Medicine Science, Cilt: 9 - Sayı: 1, 274–277. https://ajindex.com/articles/270183

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Cleeman JI. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Association. 2001;285:2486– 97
  2. Scherer J, Singh VP, Pitchumoni CS et al. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48:195-203
  3. Gofman J, Strisower B, deLalla O, et al. Index of coronary artery atherogenesis. Mod Med. 1953;21:119-40
  4. Sarwar N, Danesh J, Eiriksdottir G et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115:450-8
  5. Simpson HC, Mann JI, Meade TWet al.Hypertriglyceridaemia and hypercoagulability. Lancet. 1983;1:786-90
  6. Deng LH, Xue P, Xia Q et al. Effect of admission hypertriglyceridemia on the episodes of severe pancreatitis. World Gastroenterol. 2008;14:4558–61
  7. Whitcomb DC. Clinical practice Acute pancreatitis. N Engl JMed. 2006;354:2142–50
  8. Fredrickson DS. An international classification of hyperlipidemias and hyperlipoproteinemias. Ann Intern Med. 1971;75:471–2
  9. Sadr-Azodi O, Orsini N, Andren-Sandberg A et al. Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study. Am J Gastroenterol. 2013;108:133-9
  10. Mikhail N, Trivedi K, Page C et al. Treatment of severe hypertriglyceridemia in nondiabetic patients with insulin. Am J Emerg Med. 2005;23:415–7
  11. Näsström B, Olivecrona G, Olivecrona T, et al. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med. 2001;138:206–13
  12. Betteridge DJ, Bakowski M, Taylor KG et al. Treatment of severe diabetic hypertriglyceridemia by plasma exchange. Lancet. 1978;1:1368
  13. Winters JL. American society for apheresis guidelines on the use of apheresis in clinical practice: practical, concise, evidence-based recommendations for the apheresis practitioner. J Clin Apher. 2014;29:191-3
  14. Navina S, Acharya C, DeLany JP et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci Transl Med. 2011;3:107-10
  15. Yeh JH, ChenJH, ChiuHC. Plasmapheresis forhyperlipidemic pancreatitis, J Clin Apheresis. 2003;18:181–5
  16. Yeh JH, Lee MF, Chiu HC. Plasmapheresis for Severe Lipemia: Comparison of Serum-Lipid Clearance Rates for the Plasma-Exchange and Double-Fil